Citations

Clear

9383 citation(s) found for "Thomas, PS".

Mitral Valve Injury After Radiofrequency Ablation for Wolff-Parkinson-White Syndrome
Canal, Juan G. Penaranda, Enriquez‐Sarano, Maurice , Asirvatham, Samuel J. , Munger, Thomas M. , Friedman, Paul A. , Suri, Rakesh M. , Penaranda Canal, Juan G, Asirvatham, Samuel J , Enriquez-Sarano, Maurice

Mayo Clinic

Circulation | June 24, 2013 | Volume: 127 | Issue: 25 | Pages: 2551-2552

10.1161/circulationaha.113.002711 | PMID 23797742 Get It

Two-Tiered Approach to MRI for Headache: A Cost-Effective Way to Use an Expensive Technology
Sharma, Aseem , Reis, Martin, Wippold, Franz J. , Chrisinger, John S.A. , Schwedt, Todd J. , Pilgram, Thomas K., Parsons, Matthew S. , Schwedt, Todd J , Chrisinger, John S A

Mayo Clinic

American Journal of Roentgenology | June 21, 2013 | Volume: 201 | Issue: 1 | Pages: W75-W80

10.2214/ajr.12.10238 | PMID 23789700 Get It

Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes
Collaborative, The Beyond TME, Antoniou, Anthony , Beynon, John, Bhangu, Aneel , Bose, Pradeep, Boyle, Kirsten, Branagan, Graham , Burling, David , Chang, George J. , Clark, Susan K. , Colquhoun, Patrick, Crane, Christopher H. , Darzi, Ara , Das, Prajnan , Delaney, Conor P. , Desai, Anant, Davies, Mark, Dozois, Eric J. , Fitzgerald, J.E.F. , Frizelle, Frank , George, Bruce , George, Mark, Georgiou, Panagiotis , Gupta, Arun , Harris, Dean , Hawkins, M. , Holm, Torbjörn, Hompes, Roel , Jeys, Lee , Jenkins, John T. , Kiran, Ravi P. , Koh, Cherry , Laurberg, Søren , Law, Wai Lun, Liberman, A. Sender , McArthur, D. Ray, Mirnezami, Alex H. , Moran, Brendan , Mortenson, Neil, Myers, Eddie, Nicholls, R. John, O’Connell, P. R. , O’Dwyer, Sarah , Oliver, Alex, Pallan, Arvind, Patel, Prashant , Patel, Uday , Radley, Simon, Ramsey, Kelvin , Rasmussen, P., Richard, Carole, Rutten, H.J.T. , Sagar, P. M. , Sebag‐Montefiore, David , Stocchi, Luca , Swallow, Carol J. , Tait, Diana , Tan, Emile , Tekkis, Paris, As, Nicholas van , Vuong, T. , Wiggers, Theo , Wilson, Malcolm , Winter, Desmond C. , Woodhouse, Christopher, Collaborative, The Beyond TME, Ali, Simak , Brown, Gina , Wilt, Johannes H.W. de , Desai, Anant , Dietz, David , Duff, Michael J. B. , Dziki, Adam Janusz , Glynne‐Jones, Rob , Goldin, Robert , Harji, Deena Pravin , Heriot, Alexander G. , Marshall, Michelle Berger , Radley, Simon, Solomon, Michael J. , Jeys, Lee M

Mayo Clinic

British Journal of Surgery | June 21, 2013 | Volume: 100 | Issue: 8 | Pages: E1-E33

10.1002/bjs.9192_1 | PMID 23901427 Get It

Consensus abstract Background The management of primary rectal cancer beyond total mesorectal excision planes (PRC-bTME) and recurrent rectal cancer (RRC) is challenging. There is global variation in standards and no guidelines exist. To achieve cure most patients require extended, multivisceral, exenterative surgery, beyond conventional total mesorectal excision planes. The aim of the Beyond TME Group was to achieve consensus on the definitions and principles of management, and to identify areas of research priority. Methods Delphi methodology was used to achieve consensus. The Group consisted of invited experts from surgery, radiology, oncology and pathology. The process included two international dedicated discussion conferences, formal feedback, three rounds of editing and two rounds of anonymized web-based voting. Consensus was achieved with more than 80 per cent agreement; less than 80 per cent agreement indicated low consensus. During conferences held in September 2011 and March 2012, open discussion took place on areas in which there is a low level of consensus. Results The final consensus document included 51 voted statements, making recommendations on ten key areas of PRC-bTME and RRC. Consensus agreement was achieved on the recommendations of 49 statements, with 34 achieving consensus in over 95 per cent. The lowest level of consensus obtained was 76 per cent. There was clear identification of the need for referral to a specialist multidisciplinary team for diagnosis, assessment and further management. Conclusion The consensus process has provided guidance for the management of patients with PRC-bTME or RRC, taking into account global variations in surgical techniques and technology. It has further identified areas of research priority.
Reply to A.-S. Dieudonné et al and J.M. Rae et al
Brauch, Hiltrud , Schroth, Werner , Mürdter, Thomas E. , Winter, Stefan , Schwab, Matthias , Eichelbaum, Michel , Goetz, Matthew P. , Ingle, James N. , Brauch, Hiltrud , Schwab, Matthias

Mayo Clinic

Journal of Clinical Oncology | June 18, 2013 | Volume: 31 | Issue: 21 | Pages: 2755-2756

10.1200/jco.2013.49.6661 | PMID 24040664 Get It

Hybrid submental flaps for reconstruction in the head and neck: Part pedicled, part free
Hayden, Richard E. , Nagel, Thomas H. , Donald, Carrlene B.

Mayo Clinic

The Laryngoscope | June 17, 2013 | Volume: 124 | Issue: 3 | Pages: 637-641

10.1002/lary.24266 | PMID 23775702 Get It

Objectives/Hypothesis Evaluate feasibility and success of elongating only the venous pedicle of the submental flap to increase the superior arc of rotation for the “hybrid” flap allowing coverage of more distal defects. Study Design Retrospective evaluation of all submental flaps undergoing pedicle‐lengthening procedure at a single institution. Methods Medical records were reviewed for all patients undergoing reconstruction with submental flaps between 2002 and 2012. Information regarding demographics, etiology, location, size, and extent of defects, type of submental flap harvested, operative time, and outcomes were recorded. Special note was made of vascular pedicle length and any pedicle vessel manipulation to increase the superior arc of rotation. Results Nine patients (67% male) with a mean age of 61 years (range, 25–83 years) underwent hybrid submental flap procedures. Eight surgical defects resulted from cancer ablation and one from trauma. Five flaps were musculocutaneous, and four were osseomusculocutaneous. The divided pedicle vein was anastomosed to the external jugular vein (n = 6), retromandibular vein (n = 1), common facial vein (n = 1), and internal jugular vein (n = 1). Pedicle vessel elongation averaged 5 cm. Skin paddle size averaged 71 cm 2 (range, 48–99 cm 2 ). All donor sites were closed primarily with no further surgery required. One flap experienced venous thrombosis and was successfully salvaged. Overall flap survival was 100%. No local or regional cancer recurrence was detected in the cancer patients with a mean follow‐up of 20 months (range, 3–87 months). Conclusions The hybrid submental flap safely extends the arc of rotation 5 cm, allowing coverage of defects in the forehead, temporal‐parietal, and occipital regions. Level of Evidence 4. Laryngoscope , 124:637–641, 2014
Risks and Benefits of Anticoagulation in Atrial Fibrillation
Cullen, Michael W. , Kim, Sunghee , Piccini, Jonathan P. , Ansell, Jack , Fonarow, Gregg C. , Hylek, Elaine M. , Singer, Daniel E. , Mahaffey, Kenneth W. , Kowey, Peter R. , Thomas, Laine , Go, Alan S. , Chang, Paul, Lópes, Renato D. , Peterson, Eric D. , Gersh, Bernard J.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | June 12, 2013 | Volume: 6 | Issue: 4 | Pages: 461-469

10.1161/circoutcomes.113.000127 | PMID 23759473 Get It

Background— Patients with atrial fibrillation (AF) at the highest stroke risk derive the largest benefit from oral anticoagulation (OAC). Those with the highest stroke risk have been paradoxically less likely to receive OAC. This study assessed the association between stroke and bleeding risk on rates of OAC. Methods and Results— We analyzed OAC use among 10 098 patients with AF from 174 community-based outpatient practices enrolled in 2010–2011 in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). OAC was defined as warfarin or dabigatran use at study enrollment. Stroke and bleeding risk were calculated using congestive heart failure, hypertension, age, diabetes mellitus, prior stroke (CHADS 2 ), and anticoagulation and risk factors in AF (ATRIA) scores, respectively. The mean subject age was 73 years; 58% were men. Overall, 76% of patients received OAC (71% warfarin and 5% dabigatran). The use of OAC increased among those with higher CHADS 2 scores, from 53% for CHADS 2 =0 to 80% for CHADS 2 ≥2 ( P <0.001). OAC use fell slightly with increasing ATRIA bleeding risk score, from 81% for ATRIA=3 to 73% for ATRIA≥5 ( P <0.001). A significant interaction existed between ATRIA and CHADS 2 scores ( P =0.021). Among those with low bleeding risk, use of OAC increased significantly with increasing stroke risk. Among those with high bleeding risk, CHADS 2 stroke risk had a smaller impact on use of OAC. Conclusions— In community-based outpatients with AF, use of OAC was high and driven by not only predominantly stroke but also bleeding risk. Stroke risk significantly affects OAC use among those with low bleeding risk, whereas those with high bleeding risk demonstrate consistently lower use of OAC regardless of stroke risk.
Genomic Association Analysis of Common Variants Influencing Antihypertensive Response to Hydrochlorothiazide
Boerwinkle, Eric , O’Connell, Jeffrey R. , Bailey, Kent R. , Chapman, Arlene B. , McDonough, Caitrin W. , Beitelshees, Amber L. , Schwartz, Gary L. , Gums, John G. , Padmanabhan, Sandosh , Hiltunen, Timo P. , Citterio, Lorena , Donner, Kati , Hedner, Thomas, Lanzani, Chiara , Melander, Olle , Saarela, Janna , Wahlstrand, Björn, Manunta, Paolo , Kontula, Kimmo , Dominiczak, Anna F. , Johnson, Julie A. , Beitelshees, Amber L. , Turner, Stephen T. , Gong, Yan , Chapman, Arlene B. , Ripatti, Samuli , Cooper‐DeHoff, Rhonda M. , Padmanabhan, Sandosh , Dominiczak, Anna F.

Mayo Clinic

Hypertension | June 11, 2013 | Volume: 62 | Issue: 2 | Pages: 391-397

10.1161/hypertensionaha.111.00436 | PMID 23753411 Get It

To identify novel genes influencing blood pressure response to thiazide diuretic therapy for hypertension, we conducted genome-wide association meta-analyses of ≈1.1 million single-nucleotide polymorphisms in a combined sample of 424 European Americans with primary hypertension treated with hydrochlorothiazide from the Pharmacogenomic Evaluation of Antihypertensive Responses study (n=228) and the Genetic Epidemiology of Responses to Antihypertensive study (n=196). Polymorphisms associated with blood pressure response at P <10 –5 were tested for replication of the associations in independent samples of hydrochlorothiazide-treated European hypertensives. The rs16960228 polymorphism in protein kinase C, α replicated for same-direction association with diastolic blood pressure response in the Nordic Diltiazem study (n=420) and the Genetics of Drug Responsiveness in Essential Hypertension study (n=206), and the combined 4-study meta-analysis P value achieved genome-wide significance ( P =3.3×10 −8 ). Systolic or diastolic blood pressure responses were consistently greater in carriers of the rs16960228 A allele than in GG homozygotes (>4/4 mm Hg) across study samples. The rs2273359 polymorphism in the GNAS-EDN3 region also replicated for same-direction association with systolic blood pressure response in the Nordic Diltiazem study, and the combined 3-study meta-analysis P value approached genome-wide significance ( P =5.5×10 −8 ). The findings document clinically important effects of genetic variation at novel loci on blood pressure response to a thiazide diuretic, which may be a basis for individualization of antihypertensive drug therapy and identification of new drug targets.
Different Stages of White Matter Changes in the Original HDLS Family Revealed by Advanced MRI Techniques
Sundal, Christina , Jönsson, Lars , Ljungberg, Maria , Zhong, Jianhui , Tian, Wei , Zhu, Tong , Lindén, Thomas , Börjesson‐Hanson, Anne, Andersen, Oluf , Ekholm, Sven

Mayo Clinic

Journal of Neuroimaging | June 10, 2013 | Volume: 24 | Issue: 5 | Pages: 444-452

10.1111/jon.12037 | PMID 23751174 Get It

ABSTRACTBACKGROUNDThe temporal evolution of white matter (WM) changes on MR examinations in hereditary diffuse leukoencephalopathy with spheroids (HDLS) is largely unknown. Our purpose was to investigate the evolution of these WM changes with diffusion weighted/tensor imaging (DWI/DTI) and MR Spectroscopy (MRS).METHODSA newly diagnosed patient with HDLS from the original Swedish family was followed prospectively with 5 MRI as well as DWI/DTI and MRS examinations during 16 months.RESULTSThe DTI eigenvalues demonstrated changes that suggested early myelin and axonal disturbances in the normal appearing WM (NAWM). DWI/DTI showed a rim of decreased diffusion progressively expanding through the WM from the initial frontal periventricular zones, and indicated complete destruction of axons and myelin in the area behind the front. MRS findings were suggestive of axonal destruction in the NAWM.CONCLUSIONWe describe HDLS changes in three temporal stages of development corresponding to lesions outside, in the vicinity of, and behind a characteristic rim centrifugally progressing from the ventricular horns. The axonal disturbances indicated by MRS changes in the NAWM support a primary axonal degeneration, as proposed in the original HDLS report, rather than axonal degeneration secondary to demyelination. These findings could help in differential diagnosis of HDLS.
Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes
Collaborative, The Beyond TME, Antoniou, Anthony , Beynon, John, Bose, Pradeep, Boyle, Kirsten, Branagan, Graham , Brown, Gina , Burling, David , Chang, George J. , Clark, Susan K. , Colquhoun, Patrick, Crane, Christopher H. , Darzi, Ara , Das, Prajnan , Wilt, Johannes H. W. de, Delaney, Conor P. , Desai, Anant, Davies, Mark, Dozois, Eric J. , Fitzgerald, J.E.F. , Frizelle, Frank , George, Bruce , George, Mark, Georgiou, Panagiotis , Glynne‐Jones, R., Goldin, Robert , Gupta, Arun , Harris, Dean , Hawkins, M. , Holm, Torbjörn, Jenkins, John T. , Kiran, Ravi P. , Laurberg, Søren , Law, Wai Lun, Liberman, A. Sender , McArthur, D. Ray, Mirnezami, Alex H. , Moran, Brendan , Mortenson, Neil, Myers, Eddie, Nicholls, R. John, O’Connell, P. R. , O’Dwyer, Sarah , Oliver, Alex, Pallan, Arvind, Patel, Prashant , Radley, Simon, Ramsey, Kelvin , Rasmussen, P., Richard, Carole, Rutten, H.J.T. , Sagar, P. M. , Sebag‐Montefiore, David , Solomon, Michael J. , Stocchi, Luca , Swallow, Carol J. , Tait, Diana , Tekkis, Paris, As, Nicholas van , Vuong, T. , Wiggers, Theo , Wilson, Malcolm , Winter, Desmond C. , Woodhouse, Christopher, Coombes, R. Charles , Collaborative, The Beyond TME, Ali, Simak , Bhangu, Aneel , Desai, Anant , Dietz, David , Duff, Michael J. B. , Dziki, Adam Janusz , Harji, Deena Pravin , Heriot, Alexander G. , Hompes, Roel , Jeys, Lee , Koh, Cherry , Marshall, Michelle Berger , Patel, Uday , Radley, Simon, Tan, Emile , Solomon, Michael J

Mayo Clinic

British Journal of Surgery | June 10, 2013 | Volume: 100 | Issue: 8 | Pages: 1009-1014

10.1002/bjs.9192 | PMID 23754654 Get It

Consensus abstract Background The management of primary rectal cancer beyond total mesorectal excision planes (PRC-bTME) and recurrent rectal cancer (RRC) is challenging. There is global variation in standards and no guidelines exist. To achieve cure most patients require extended, multivisceral, exenterative surgery, beyond conventional total mesorectal excision planes. The aim of the Beyond TME Group was to achieve consensus on the definitions and principles of management, and to identify areas of research priority. Methods Delphi methodology was used to achieve consensus. The Group consisted of invited experts from surgery, radiology, oncology and pathology. The process included two international dedicated discussion conferences, formal feedback, three rounds of editing and two rounds of anonymized web-based voting. Consensus was achieved with more than 80 per cent agreement; less than 80 per cent agreement indicated low consensus. During conferences held in September 2011 and March 2012, open discussion took place on areas in which there is a low level of consensus. Results The final consensus document included 51 voted statements, making recommendations on ten key areas of PRC-bTME and RRC. Consensus agreement was achieved on the recommendations of 49 statements, with 34 achieving consensus in over 95 per cent. The lowest level of consensus obtained was 76 per cent. There was clear identification of the need for referral to a specialist multidisciplinary team for diagnosis, assessment and further management. Conclusion The consensus process has provided guidance for the management of patients with PRC-bTME or RRC, taking into account global variations in surgical techniques and technology. It has further identified areas of research priority.